Plasma levels of matrix metalloproteinase‐9 (MMP‐9) are associated with cognitive performance in patients with schizophrenia
Abstract Aim Matrix metalloproteinase‐9 (MMP‐9) has been shown to modulate synaptic plasticity and may contribute to the pathophysiology of schizophrenia. This study investigated the peripheral levels of MMP‐9 and its association with cognitive functions in patients with schizophrenia to see the pos...
Saved in:
Main Authors: | Noriko Kudo (Author), Hidenaga Yamamori (Author), Tamaki Ishima (Author), Kiyotaka Nemoto (Author), Yuka Yasuda (Author), Michiko Fujimoto (Author), Hirotsugu Azechi (Author), Tomihisa Niitsu (Author), Shusuke Numata (Author), Manabu Ikeda (Author), Masaomi Iyo (Author), Tetsuro Ohmori (Author), Masaki Fukunaga (Author), Yoshiyuki Watanabe (Author), Kenji Hashimoto (Author), Ryota Hashimoto (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis
by: Shusuke Numata, et al.
Published: (2018) -
Comparison of eye movements in schizophrenia and autism spectrum disorder
by: Tomoko Shiino, et al.
Published: (2020) -
Japanese youth athletes' mental health and psychological resilience during the COVID-19 pandemic <subtitle>A cross-sectional study</subtitle>
by: Fumiaki Yano, et al.
Published: (2024) -
Longitudinal reduction in brain volume in patients with schizophrenia and its association with cognitive function
by: Ryuichi Yamazaki, et al.
Published: (2024) -
Frequency of mental disorders among chronic pain patients with or without fibromyalgia in Japan
by: Kenji Miki, et al.
Published: (2018)